Published: Sep 26, 2020

by: CannaBuff

UB signs Deal with The Center for Discovery to Research Cannabinoids & Autism

The University at Buffalo’s Center for Integrated Biomedical Sciences signed yet another deal with The Center for Discovery (TCFD). TCFD is a New York State Center of Excellence that provides medical care and educational services for individuals with developmental disabilities.

Part of the deal includes plans to investigate cannabinoids in Autism Spectrum Disorder (ASD) and drug-resistant epilepsy.

ASD is a developmental disability affecting communication and behavior. Individuals with ASD are more likely to have epilepsy compared to the general population. Previous studies investigating cannabinoids for ASD have shown promise.

The collaboration will also leverage TCFD data to conduct and grow translational research programs.

Suggested Reading:

UB, Center for Discovery partner to advance critical research of autism and other complex conditions


CannaBuff mag is the leading independent source of cannabis journalism in New York. Stay up to date on regulatory changes, business updates, and research about cannabis by reading our FREE quarterly publication that's available throughout WNY or subscribe by mail or email.